⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
MLTX News
MoonLake Immunotherapeutics Class A Ordinary Shares
MoonLake Immunotherapeutics Class Action: The Gross Law Firm Reminds MoonLake Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of December 15, 2025 - MLTX
prnewswire.com
MLTX
DEADLINE NEXT WEEK: Berger Montague Advises MoonLake Immunotherapeutics (NASDAQ: MLTX) Investors to Contact the Firm Before December 15, 2025
prnewswire.com
MLTX
MLTX INVESTOR NOTICE: MoonLake Immunotherapeutics Stock Dropped 90% after Drug Trial Results; Contact BFA Law about the Pending Securities Class Action
globenewswire.com
MLTX
SueWallSt Podcast Update: Levi & Korsinsky Details MLTX Class Action Claims
accessnewswire.com
MLTX
MLTX Investors Have Opportunity to Lead MoonLake Immunotherapeutics Securities Fraud Lawsuit with the Schall Law Firm
prnewswire.com
MLTX
MLTX Stockholders Have Opportunity to Lead MoonLake Immunotherapeutics Class Action Lawsuit – Contact Bronstein, Gewirtz and Grossman, LLC Today!
accessnewswire.com
MLTX
MOONLAKE CLASS ACTION ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against MoonLake Immunotherapeutics and Encourages Investors to Contact the Firm
globenewswire.com
MLTX
Pomerantz LLP Notifies Shareholders of Lawsuit Filed Against MoonLake Immunotherapeutics – MLTX
accessnewswire.com
MLTX
MLTX LEGAL REMINDER: MoonLake Immunotherapeutics Class Action Deadline December 15 - Investors Notified to Contact BFA Law to Protect Your Rights
accessnewswire.com
MLTX
TSLA
Burned by MoonLake Immunotherapeutics? Contact Levi & Korsinsky to SueWallSt And Fight Back
accessnewswire.com
MLTX